676629-17-7

Upstream product

• 676626-92-9 6-(2,3-dichloro-phenylamino)-4-trifluoromethyl-nicotinic acid 
• 2516-34-9 cyclobutylamine 
• 42265-79-2 2,3-dichloro-N-methylaniline 
• 608-27-5 2,3-dichloroaniline 
• 676626-90-7 6-(2,3-dichloro-phenylamino)-4-trifluoromethyl-nicotinic acid methyl ester 
• 261635-79-4 methyl 6-chloro-4-(trifluoromethyl)pyridine-3-carboxylate 

Relevant academic research and scientific papers

COMBINATION OF CB2 MODULATORS AND PDE4 INHIBITORS FOR USE IN MEDICINE

Combination of one or more CB2 modulators such as a compound of formula (I), (II) and (III); and one more PDE4 inhibitors are useful of treating conditions which are mediated by the activity of CB2 receptors or conditions which are mediated by PDE4, such

PYRIDINE DERIVATIVES AS CB2 RECEPTOR MODULATORS

The present invention relates to novel pyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease

PYRIDINE DERIVATIVES AS CB2 RECEPTOR MODULATORS

The present invention relates to novel pyridine derivatives of formula (I) pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increas